KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2025)

AbCellera Biologics (ABCL) has disclosed Exchange Rate Effect for 5 consecutive years, with $290000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 113.43% year-over-year to $290000.0, compared with a TTM value of $1.1 million through Dec 2025, up 141.92%, and an annual FY2025 reading of $1.1 million, up 141.92% over the prior year.
  • Exchange Rate Effect was $290000.0 for Q4 2025 at AbCellera Biologics, up from -$544000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2023 and bottomed at -$8.6 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$597750.0, with a median of -$208500.0 recorded in 2022.
  • The sharpest move saw Exchange Rate Effect tumbled 3841.01% in 2022, then soared 1869.77% in 2025.
  • Year by year, Exchange Rate Effect stood at -$525000.0 in 2021, then soared by 169.33% to $364000.0 in 2022, then skyrocketed by 193.41% to $1.1 million in 2023, then crashed by 302.25% to -$2.2 million in 2024, then soared by 113.43% to $290000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for ABCL at $290000.0 in Q4 2025, -$544000.0 in Q3 2025, and $761000.0 in Q2 2025.